The JOURNAL OF SAFETY RESEARCH, published by Pergamon-Elsevier Science Ltd, stands as a premier platform for scholarly discourse within the domain of safety, risk, reliability, and quality. With an esteemed impact factor and a strong ranking of #38 out of 207 in its category as per Scopus, this journal maintains a distinguished Q1 quartile status, reflecting its influence and significance in advancing safety research since its inception in 1969. Researchers, practitioners, and students alike will find a wealth of knowledge here as the journal explores critical aspects of safety in various contexts, highlighting innovative strategies and empirical findings that contribute to improved safety outcomes globally. Though it operates under a traditional access format, the journal’s extensive repository of articles ensures that vital information remains accessible to its readership. The JOURNAL OF SAFETY RESEARCH is not only a cornerstone for those within the safety engineering field, but also a vital resource for professionals seeking to enhance their understanding of risk management and quality assurance methodologies.

The Journal of Health and Safety at Work, published by the Iranian Occupational Health Association, is a vital resource for researchers, professionals, and students engaged in the fields of occupational health, safety, and environmental management. With an ISSN of 2251-807X and E-ISSN 2383-2088, this Open Access journal has been dedicated to disseminating knowledge since 2012, ensuring that critical research is accessible to a global audience. The journal’s scope encompasses a diverse range of topics including human factors and ergonomics, safety research, and public health, with a focus on enhancing workplace safety and environmental standards. Although currently positioned in the Q4 category across various disciplines within safety and health research, the journal offers a unique platform for emerging studies and innovative practices, making it a significant contributor to the discourse in these fields. The journal's commitment to open access aligns with the growing trend of transparent scholarship, thus facilitating the sharing of vital insights to improve workplace health and safety outcomes. Researchers aiming to publish groundbreaking studies in this pivotal area will find the Journal of Health and Safety at Work an indispensable avenue for advancing knowledge and fostering professional collaboration.

Expert Opinion on Drug Safety is a prestigious academic journal dedicated to advancing knowledge in the fields of drug safety and pharmacology. Published by Taylor & Francis Ltd, this journal serves as an essential resource for researchers and professionals seeking to explore the complexities of drug interactions, adverse effects, and risk management. With an impressive impact factor and recognized as a Q1 journal in both the Medicine (Miscellaneous) and Pharmacology (Medical) categories, it ranks favorably at #78 out of 272 in Scopus, placing it in the 71st percentile among its peers. Operating under a rigorous peer-review process, the journal publishes original research, expert reviews, and opinion pieces that contribute to a deeper understanding of drug safety practices. While not an open access journal, it remains a vital platform for disseminating pivotal findings and fostering scholarly dialogue, ensuring that critical insights reach a global audience. With continuous publication from 2002 to 2024, Expert Opinion on Drug Safety is a key reference for anyone involved in pharmaceutical research, healthcare practice, or drug regulation.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, an esteemed publication in the field of pharmacology, is published by Wiley-Hindawi and has been at the forefront of clinical research since its inception in 1976. Operating primarily from the United Kingdom, this journal features a diverse array of articles that encompass both fundamental and practical aspects of clinical pharmacy, thereby supporting the advancement of therapeutic practices. With an ISSN of 0269-4727 and an E-ISSN of 1365-2710, it is indexed in key databases and holds respectable ranks within its categories; achieving Q3 in Pharmacology and Q2 in Medical Pharmacology in the latest quartile rankings. Its Scopus ranking reflects both its quality and relevance, being positioned in the 55th percentile for medical pharmacology and the 45th for pharmacology, toxicology, and pharmaceutics. Although it does not currently operate under an Open Access model, the journal's extensive readership and rigorous peer-review process ensure that the latest research reaches practitioners and academics alike. With a commitment to bridging the gap between pharmacological science and clinical practice, the JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS remains a critical resource for professionals striving to enhance patient outcomes through informed medication management.

Drugs-Real World Outcomes, published by SPRINGERNATURE, is an influential open access journal dedicated to the dissemination of research concerning the real-world impact of pharmacological therapies. Since its inception in 2014, this journal has established a significant presence in the field of Pharmacology, evidenced by its classification in the Q2 quartile for 2023 and a Scopus rank of #141 out of 272 in the medical pharmacology category, placing it in the 48th percentile. The journal’s scope encompasses a diverse range of studies aimed at bridging the gap between clinical research and practical outcomes, making it an essential resource for researchers, healthcare professionals, and students alike. Located in Switzerland, Drugs-Real World Outcomes allows researchers unfettered access to vital data, enhancing knowledge translation and improving health care practices. As it continues to evolve, the journal remains committed to fostering high-quality research that informs and advances the field of pharmacological therapies.

JOURNAL OF PHARMACY TECHNOLOGY is a premier publication in the field of Pharmaceutical Science, established in 1989 and published by SAGE PUBLICATIONS INC. This journal serves as an essential resource for professionals, researchers, and students dedicated to the advancements in pharmacy technology and the application of innovative solutions in pharmaceutical practices. With an ISSN of 8755-1225 and an E-ISSN of 1549-4810, the journal provides a rigorous peer-reviewed platform for disseminating cutting-edge research and case studies. As of 2023, it is ranked Q3 in the Scopus categories of Pharmacology, Toxicology, and Pharmaceutics, highlighting its relevance in the field. Although it currently does not offer an Open Access option, JOURNAL OF PHARMACY TECHNOLOGY aims to remain a critical avenue for scholarly communication and knowledge dissemination among practitioners in the pharmaceutical sector, ensuring they stay informed of the latest trends and findings that impact their work.

INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, published by IOS Press, serves as an essential platform for advancing the understanding of risk and safety within the medical domain. With an ISSN of 0924-6479 and E-ISSN of 1878-6847, this journal has been dedicated to fostering critical discourse since its inception in 1990, reflecting a continuous commitment to the field through 2024. Positioned within the Q4 category in Health Policy and Q3 in Medicine (miscellaneous) and Public Health, Environmental and Occupational Health, the journal provides valuable insights, empirical research, and theoretical analyses that speak to the diverse challenges faced in medical safety and risk management. Although it operates under a subscription model, the journal remains a vital resource for researchers, healthcare professionals, and students alike, facilitating the exchange of innovative ideas and best practices in health risk assessment. With Scopus ranks indicating its role as a key contributor in its categories, the INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE continues to shape the landscape of medical safety and policy discussions around the globe.

British Journal of Clinical Pharmacology, published by Wiley, is a premier peer-reviewed journal that has been at the forefront of pharmacology research since its inception in 1974. Renowned for its high academic rigor, it stands out with an impressive impact factor that places it in the Q1 quartile within both the general pharmacology and medical pharmacology categories. With a Scopus ranking reflecting its esteemed status—ranked #68 out of 272 in medical pharmacology and #109 out of 313 in pharmacology, toxicology, and pharmaceutics—the journal serves as a critical resource for researchers, clinicians, and students who are keen to explore innovations and advancements in drug therapy. The journal's scope encompasses a wide array of topics, including clinical trials, drug safety, and pharmacokinetics, making it an essential platform for disseminating cutting-edge pharmacological findings. Although it does not offer open access, the stringent selection of articles ensures that only the highest-quality research is published, further contributing to the ongoing discourse in clinical pharmacology.

ANNALS OF PHARMACOTHERAPY, published by SAGE PUBLICATIONS INC, is a leading journal in the realm of pharmacology and therapeutic science, dedicated to advancing research, clinical practice, and education in the field of medicine. With a solid history dating back to its first publication in 1981, this journal offers a platform for high-quality research articles that explore the latest innovations and methodologies in pharmacotherapy. Although it operates under a subscription-based model, the journal maintains a robust academic reputation, reflected in its Scopus ranking in the 68th percentile within the category of Medicine - Pharmacology (Rank #85/272). The impact factor is continually evolving, as is the scope, which encompasses a diverse range of topics from clinical trials to the therapeutic applications of newly-developed drugs. Researchers, professionals, and students alike will find valuable insights and cutting-edge research in the ANNALS OF PHARMACOTHERAPY, making it an essential resource for anyone engaged in the field of pharmacology.

International Journal of Occupational Safety and Ergonomics, ISSN 1080-3548, is a leading multidisciplinary journal published by TAYLOR & FRANCIS LTD with a dedicated focus on advancing research and practices in occupational safety and ergonomics. Since its inception in 1995, this journal has provided a platform for the dissemination of innovative studies that address critical issues in public health, environmental and occupational health, and safety research. Recognized for its rigorous peer-review process, the journal holds a respectable position in the Q2 quartile rankings across multiple categories as of 2023, reflecting its impact and relevance within the academic community. It ranks 24th out of 109 in Safety Research, 198th out of 665 in Public Health, and 66th out of 207 in Safety, Risk, Reliability and Quality, showcasing its influence in these essential fields. The journal's broad scope aims to bridge gaps between research and application, ensuring that findings contribute to effective safety practices in various industries. While not an Open Access journal, the International Journal of Occupational Safety and Ergonomics remains an invaluable resource for researchers, professionals, and students seeking to stay informed about the evolving landscape of occupational safety. Its headquarters are located in Abingdon, England, serving as a conduit for scholarly communication in this vital area of study.